TY - JOUR
T1 - Comparative Trends in Percutaneous Coronary Intervention in Japan and the United States, 2013 to 2017
AU - Inohara, Taku
AU - Kohsaka, Shun
AU - Spertus, John A.
AU - Masoudi, Frederick A.
AU - Rumsfeld, John S.
AU - Kennedy, Kevin F.
AU - Wang, Tracy Y.
AU - Yamaji, Kyohei
AU - Amano, Tetsuya
AU - Nakamura, Masato
N1 - Funding Information:
This study was funded by the Grant-in-Aid from Scientific Research from the Japan Agency for Medical Research and Development (grant No. 17ek0210097h000) and the Japan Society for the Promotion of Science (grant Nos. 20H03915, 16H05215 and 16KK0186). The J-PCI registry is a registry led and supported by the Japanese Association of Cardiovascular Intervention and Therapeutics. Dr. Kohsaka has received investigator-initiated grant funding from Bayer and Daiichi-Sankyo; and has received personal fees from Bayer and Bristol-Myers Squibb. Dr. Spertus owns equity in Health Outcomes Sciences outside the submitted work. Dr. Masoudi has served as chief scientific advisor for the National Cardiovascular Data Registry of the American College of Cardiology. Dr. Amano has received lecture fees from Astellas Pharma, AstraZeneca, Bayer, Daiichi-Sankyo, and Bristol-Myers Squibb. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Funding Information:
This study was funded by the Grant-in-Aid from Scientific Research from the Japan Agency for Medical Research and Development (grant No. 17ek0210097h000) and the Japan Society for the Promotion of Science (grant Nos. 20H03915, 16H05215 and 16KK0186). The J-PCI registry is a registry led and supported by the Japanese Association of Cardiovascular Intervention and Therapeutics. Dr. Kohsaka has received investigator-initiated grant funding from Bayer and Daiichi-Sankyo; and has received personal fees from Bayer and Bristol-Myers Squibb. Dr. Spertus owns equity in Health Outcomes Sciences outside the submitted work. Dr. Masoudi has served as chief scientific advisor for the National Cardiovascular Data Registry of the American College of Cardiology. Dr. Amano has received lecture fees from Astellas Pharma, AstraZeneca, Bayer, Daiichi-Sankyo, and Bristol-Myers Squibb. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2020 American College of Cardiology Foundation
PY - 2020/9/15
Y1 - 2020/9/15
N2 - Background: Adoption of the results of large-scale randomized controlled trials in percutaneous coronary intervention (PCI) may differ internationally, yet few studies have described the potential variations in PCI practice patterns. Objectives: Using representative national registries, we compared temporal trends in procedural volume, patient characteristics, pre-procedural testing, procedural characteristics, and quality metrics in the United States and Japan. Methods: The National Cardiovascular Data Registry CathPCI was used to describe care in the United States, and the J-PCI was used to assess practice patterns in Japan (numbers of participating hospitals: 1,752 in the United States and 1,108 in Japan). Both registries were summarized between 2013 and 2017. Results: PCI volume increased by 15.8% in the United States from 550,872 in 2013 to 637,650 in 2017, primarily because of an increase in nonelective PCIs (p for trend <0.001). In Japan, the volume of PCIs increased by 36%, from 181,750 in 2013 to 247,274 in 2017, primarily because of an increase in elective PCIs (p for trend <0.001). The proportion of PCI cases for elective conditions was >2-fold greater in Japan (72.7%) than in the United States (33.8%; p < 0.001). Overall, the ratio of nonelective PCI (vs. elective PCI; 27.3% vs. 66.2%; p < 0.001) and the performance of noninvasive stress testing in patients with stable disease (15.2% vs. 55.3%; p < 0.001) was lower in Japan than in the United States. Computed tomography angiography was more commonly used in Japan (22.3% vs. 2.0%; p < 0.001). Conclusions: Elective PCI is more than twice as common in Japan as in the United States in contemporary practice. Computed tomography angiography is much more frequently used pre-procedurally in Japan than in the United States.
AB - Background: Adoption of the results of large-scale randomized controlled trials in percutaneous coronary intervention (PCI) may differ internationally, yet few studies have described the potential variations in PCI practice patterns. Objectives: Using representative national registries, we compared temporal trends in procedural volume, patient characteristics, pre-procedural testing, procedural characteristics, and quality metrics in the United States and Japan. Methods: The National Cardiovascular Data Registry CathPCI was used to describe care in the United States, and the J-PCI was used to assess practice patterns in Japan (numbers of participating hospitals: 1,752 in the United States and 1,108 in Japan). Both registries were summarized between 2013 and 2017. Results: PCI volume increased by 15.8% in the United States from 550,872 in 2013 to 637,650 in 2017, primarily because of an increase in nonelective PCIs (p for trend <0.001). In Japan, the volume of PCIs increased by 36%, from 181,750 in 2013 to 247,274 in 2017, primarily because of an increase in elective PCIs (p for trend <0.001). The proportion of PCI cases for elective conditions was >2-fold greater in Japan (72.7%) than in the United States (33.8%; p < 0.001). Overall, the ratio of nonelective PCI (vs. elective PCI; 27.3% vs. 66.2%; p < 0.001) and the performance of noninvasive stress testing in patients with stable disease (15.2% vs. 55.3%; p < 0.001) was lower in Japan than in the United States. Computed tomography angiography was more commonly used in Japan (22.3% vs. 2.0%; p < 0.001). Conclusions: Elective PCI is more than twice as common in Japan as in the United States in contemporary practice. Computed tomography angiography is much more frequently used pre-procedurally in Japan than in the United States.
KW - percutaneous coronary intervention
KW - quality metrics
KW - quality of care
KW - registry
UR - http://www.scopus.com/inward/record.url?scp=85089999187&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089999187&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2020.07.037
DO - 10.1016/j.jacc.2020.07.037
M3 - Article
C2 - 32912447
AN - SCOPUS:85089999187
SN - 0735-1097
VL - 76
SP - 1328
EP - 1340
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 11
ER -